17 November 2012 1 6K Report

I am looking for help identifying all the various constraints, limitations or difficulties in discovery, pre-clinical and clinical pharmacology. Here are some examples we are working to eliminate or limit:

Inconsistent biologics (cell lines, animal lines, reagents etc.)

Failure rates in results duplication

Various biases, design, interpretation

Open source vs. closed source data

Acceptable methods to open up communication and collaboration

We have no doubt you have others. Can you help a small group next to Stanford find a way to move research forward faster while preserving individual and corporate credit and rights? Any suggestions?

More Jeff Rusteen's questions See All
Similar questions and discussions